Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference30 articles.
1. Anal canal carcinoma: Early-stage tumors < or =10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy;Ortholan;Int J Radiat Oncol Biol Phys,2005
2. Anal canal cancer treatment: Practical limitations of routine prescription of concurrent chemotherapy and radiotherapy;Chauveinc;Br J Cancer,2003
3. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
4. Role of mitomycin in combination with fluorouracil and radiotherapy, of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study;Flam;J Clin Oncol,1996
5. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil–cisplatinum. Long-term results in 95 patients;Gerard;Radiother Oncol,1998
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments;Brachytherapy;2023-07
2. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma;Strahlentherapie und Onkologie;2023-03-02
3. Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis;Clinical and Translational Radiation Oncology;2023-03
4. High dose rate brachytherapy in the management of anal cancer: A review;Radiotherapy and Oncology;2022-06
5. Anal cancer brachytherapy: From radon seeds to interstitial Papillon technique in a century. What does the future hold?;Radiotherapy and Oncology;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3